← Evidence map

ArticleFrontiers of medicine2023

Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma.

Yubing Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36580233